Rahul Singhvi, Resilience CEO
Resilience notches $410M in federal financing to bolster production
Biopharma manufacturer Resilience has netted a major investment from the US Department of Defense.
Resilience inked a financing agreement for a $410 million long-term loan from the DOD, working with the US International Development Finance Corporation. The loan will be used to bolster Resilience’s domestic biomanufacturing capacity and capabilities for several products, according to a press release. This includes biologics such as antibodies, proteins, vaccines and mRNA products.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters